Emerging evidence suggests that changes in the gut microbiome could be connected to the rise in food-related diseases, particularly celiac disease and food allergies. This webinar will discuss how the gut microbiome contributes to these diseases and new efforts to use microbiota-based therapies to treat them.
Keynote Speaker: Alexa Weingarden, MD, PhD
Dr. Weingarden graduated from the Medical Scientist Training Program at the University of Minnesota in 2017. She completed her PhD in the Microbiology, Immunology, and Cancer Biology program with Alex Khoruts and Mike Sadowsky, where her work focused on understanding the mechanisms behind fecal microbiota transplantation for recurrent C. difficile infection. After medical school, she went on to residency in Internal Medicine followed by Gastroenterology fellowship, both at Stanford University. While at Stanford she also completed postdoctoral research with Michael Fischbach, where she investigated the role of gut microbes in food allergy and engineered commensal gut bacteria to drive antigen-specific T cell responses. Dr. Weingarden’s current research is focused on microbial and immune interactions in celiac disease and food allergy.
Interested in participating in celiac research studies? Reach out to celiac@umn.edu for more information.
Please contact ACT at info@achievingcures.com with any additional questions.
